To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.

10/12/2024, 8:05 AM

Current Status of Bill HR 9979

Bill HR 9979 is currently in the status of Bill Introduced since October 11, 2024. Bill HR 9979 was introduced during Congress 118 and was introduced to the House on October 11, 2024.  Bill HR 9979's most recent activity was Referred to the House Committee on Energy and Commerce. as of October 11, 2024

Bipartisan Support of Bill HR 9979

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 9979

Primary Policy Focus


Alternate Title(s) of Bill HR 9979

To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.To amend the Federal Food, Drug, and Cosmetic Act to establish a process for externally led, science-focused drug development meetings, and for other purposes.
Start holding our government accountable!

Comments